SUMMARY A commercially available polyclonal antiserum (Dakopatts) raised against bovine neuron specific enolase (NSE) was reacted with 197 sarcomas, 32 carcinomas, 11 carcinoid tumours and 20 malignant melanomas to assess its specificity for neuroendocrine tumours. All the tumours had been fixed in formalin and embedded in paraffin. Positive tumour cells were found in two of 11 squamous cell carcinomas, one of 11 adenocarcinomas, 10 of 10 oat cell carcinomas, 11 of 11 carcinoid tumours, 16 of 20 malignant melanomas, four of seven clear cell sarcomas, nine of 25 leiomyosarcomas, four of 22 rhabdomyosarcomas, one of seven angiosarcomas and one of 20 synovial sarcomas.
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Neuron specific enolase (NSE) (yy) is an isoenzyme of the glycolytic enzyme enolase.' It was first localised in neurones but was subsequently found in neuroendocrine derived cells throughout the body.2 3 The antibodies raised against this antigen are widely used as tumour markers of neuroendocrine derived neoplasms. Although certainly useful in this respect, no study has adequately examined the specificity of commercially available NSE antibodies for neuroendocrine tumours. This information is obviously essential if NSE is to be used as a reliable tumour marker. As staining for NSE using the immunocytochemical peroxidase-antiperoxidase (PAP) method can be technically quite difficult and as the reagents are expensive, it is important that the optimal staining methods are well documented and the pitfalls associated with using this reagent well publicised. With these factors in mind, this study examined 32 carcinomas, 11 carcinoid tumours, 20 malignant melanomas and 197 sarcomas using a polyclonal commercially available antibody (Dakopatts) to NSE. All tumours studied had been fixed in formalin and embedded in paraffin.
Material and methods
Thirty two carcinomas, 11 carcinoid tumours, 20 malignant melanomas and 197 sarcomas were Accepted for publication 14 May 1986 included in this study. All were fixed in neutral buffered formalin and all were embedded in paraffin. The sarcomas were obtained from the files of this hospital. The age of the blocks ranged from 1-28 years. All sarcomas were examined by Professor DH MacKenzie.4 These were diagnosed mainly on the basis of haematoxylin and eosin staining and nonimmunocytochemical special stains. In "difficult" tumours and where material was available electron microscopy was carried out. The remaining tumours were chosen retrospectively from the files of this hospital and ranged in age from 1-4 years.
NSE antiserum (Dakopatts) consists of polyclonal antibodies raised against bovine NSE. Its reliability was initially tested on a series of positive controls (nerve bundles). The reagent was also tested at differing dilutions and at varying temperatures and on sections which had and had not been trypsinised. The staining procedure used was the peroxidaseantiperoxidase technique. The best and most reliable results were obtained without trypsinisation, using a dilution of 1/4000 with overnight incubation and continuous agitation. Good results, however, were also obtained using a dilution of 1/400 with one hour of incubation. As the former method gave optimal results and it was considerably less expensive, this was the procedure used: I Dewax 4 pm and 5 um sections and take to absolute alcohol. 2 Immerse in 3% H202 in MeOH for 20 Each coded section was examined using a x 4, x 10, and x 40 objective on each section. A positive or negative result was reported in the absence of the haematoxylin and eosin diagnosis. Only the presence of discrete cytoplasmic staining was accepted as a positive result. The case numbers were then decoded and the result of the staining tabulated against each tumour.
SPECIAL NOTES ON THE STAINING METHOD USING NSE ANTISERUM
I Slides may be coated or uncoated. Slides must, however, be placed on a hot plate until the paraffin wax surrounding the sections begins to melt and they must then be removed to an incubator (37°C) for a minimum of one night. 2 Sections with melanin require the following special treatment:
(i) Coating of slides is imperative.
(ii) Melt wax as described above.
(iii) Bleach melanin. After quenching the endogenous peroxidase and hydration, but before normal swine serum, bleach in 1% potassium permanganate followed, after washing, by 1% oxalic acid. Wash thoroughly. Times will depend on the amount of melanin and will, presumably, be known from routine haematoxylin and eosin staining. (iv) Incubate with anti-NSE at 1/400 for one hour at room temperature with gentle agitation and with 2°C and 30C at 1/100 for 30 minutes with agitation and the usual washes. Use DAB as usual for 10 minutes. 3 The shortened incubation time for sections containing melanin is to reduce the risk of the sections floating off or disintegrating after bleaching. It may, of course, also be used where a speedy result is required.
4 On some sections there is a heavy brown deposit, probably of DAB. We tried unsuccessfully to exclude this by centrifugation and by varying the pH of the TBS from 7-4 to 7-8. It does seem to be reduced, however, by using a DAB solution that has been aliqoted and stored at -20°C. 5 Staining of sections seems to be more intense at the edges than in the interior. This may be due to cutting damage; it is reduced by using agitation during incubation. 6 More recent batches of NSE antiserum available from Dakopatts, require lower dilutions of anti-NSE than used in this study.
Results
Thirty two carcinomas, 11 carcinoid tumours, 20 malignant melanomas and 197 sarcomas were stained with anti-NSE. Tables 1 and 2 summarise the results. Normal eccrine glands, smooth muscle, and skeletal muscle included in many of the sections stained positively. Occasional histiocytes within the sinuses of reactive nodes stained positively, as did the respiratory mucosa lining and bronchi.
CARCINOMAS, CARCINOID TUMOURS, AND MALIGNANT MELANOMAS (TABLE I) Two of 10 squamous cell carcinomas stained posi- Britain and Northern Ireland, 150th meeting, 1985). All 11 carcinoid tumours stained positively (fig 2) . The number of positively staining cells varied from case to case. Sixteen of 20 malignant melanomas stained positively. Some of these had been bleached before staining with anti-NSE so that pigment would not be confused with a positive result. An earlier pilot study on positive controls confirmed that bleaching did not interfere with NSE immunocytochemical staining.
SARCOMAS (TABLE 2) Four of seven clear cell sarcomas stained positively. In two cases most tumour cells stained positively. In the remaining two cases the staining pattern was curious: the positive areas were seen as sheets of positively staining cells, admixed with cytologically similar sheets of cells that stained negatively, giving an overall streaky pattern of staining to the sections. At first we thought this type of staining pattern might be an artefact, but on repeating the staining a similar pattern was obtained on two further occasions. There was no evidence of pigment in either of these two cases with light microscopy. The three negatively staining clear cell sarcomas were classical examples of this type of tumour and on reviewing their sections we were in no doubt that the diagnosis was correct. The NSE staining was repeated and all again showed negative staining. Nine of 25 leiomyosarcomas and four of 22 rhabdomyosarcomas stained positively (fig 3) . Although the staining was discrete and confined to the cytoplasm it was not always granular. In many of the leiomyosarcomas most cells stained positively, but in others the pattern of staining was uneven and was reminiscent of that seen in two of the clear cell sarcomas. The positive rhabdomyosarcomas showed cross striations in two cases. The remaining two were embryonal rhabdomyosarcomas. A large number of tumour cells in all cases stained. One of seven angiosarcomas stained positively. The endothelial nature of this tumour had previously been confirmed by positive factor VIII related antigen staining. The spindle cell component of one of 20 synovial sarcomas stained positively; the "glandular" component in all stained negatively.
Discussion
Enolase isoenzymes are dimeric proteins formed from three subunits, a, /, and y. The isoenzyme aa is found mainly in liver and the isoenzyme ,B mainly in skeletal muscle. In brain, however, a mixture of isoenzymes is found: neuron specific enolase (NSE) yy, non-neuronal enolase (NNE) aa; and the hybrid enolase ccy.5 6 NSE was so named because initially it Leader, Collins, Patel, Henry was found only in neurones.7 It is a protein consisting of two identical subunits, each having a molecular weight of 39 000 daltons. 8 9 It seems that NNE (cxa) is the dominant enzyme in fetal brain'0 -12 and that NSE (yy) may be a marker of neural differentiation.5 The functional characteristics of NSE and NNE disclose important differences,'3 and may explain why neurones switch from NNE to NSE during differentiation' and wihy the cellular specificity of NSE is relaxed in neoplasia. 14 NSE has been identified in a large number of tissues and tumours derived from the neuroendocrine system, including the following: apud cells of the thyroid, pituitary, adrenal medulla, pancreatic islets,2 lung,'5 skin'6 and gut.7 It has also been localised in many neuroendocrine tumours,'7 in pancreatic islet cell tumours,'8 in neuroblastomas,19 21 The results of this study show that NSE is not a specific marker of neuroendocrine cells. This lack of specificity is not confined to the Dakopatts antibody as it has also been found by other workers using differing sources of antibody. Haimoto etal,29 who have made important advances in the isolation of enolase isoenzymes and in the development of sensitive and specific assays for the various brain isoenzymes, reported on the immunolocalisation of the y subunit in cell classes that are non-neuronal and nonendocrine. Having reacted antibodies raised in their laboratory against the y subunit of human enolase, they reported positivity in bronchial epithelial cells The specificity of the y subunit of enolase has been discussed.32 The conclusion reached is that it is neither non-specific nor neuron specific. A review of published reports on the subject provides scanty information regarding the staining reactions of NSE antiserum and mesenchymal tumours. A leiomyoma of the uterus and a rhabdomyosarcoma described by Vinores The positive staining of clear cell sarcomas in this study is to be expected if one accepts that these tumours are the soft tissue counterpart of malignant melanomas. Such a histogenesis has been advanced by Chung and Enzinger.33 Electron microscopy also supports this view as melanosomes have been shown at ultrastructural level. 34 The positive staining of leiomyosarcomas and rhabdomyosarcomas is not unexpected bearing in mind that enolase has three distinct subunits-liver (a), muscle (f), and neuron specific (y).5 Cross reactions between these subunits when using NSE antiserum presumably explains the common staining of normal smooth muscle and skeletal muscle.2 21
The positive staining of the angiosarcoma in this study is puzzling. Under normal circumstances endothelial cells do not stain positively for NSE, although Dhillon and Rode35 state that overincubation with substrate may produce staining of blood vessels. It is possible, therefore, that the positive staining represents a false positive result. As for the positive staining of the biphasic synovial sarcoma, this again may suggest a false positive result. The tumour had not previously been irradiated. Some workers, however, might argue that a positive NSE staining pattern in a synovial sarcoma lends support to the concept that synovial sarcomas are closely related tp clear cell sarcomas.36
Other workers have compared NSE antiserum from varying sources, using different staining techniques. Tsokos etat2' compared the commercially available Polysciences antisera with that of Marangos' non-commercially available antisera and found that the Petrusky Ig-enzyme bridge method yielded the most reliable and consistent results among the immunocytochemical methods tested. They found Sternberger's PAP method was associated with a higher percentage of false positive results and with background staining. The Polysciences antisera showed variations both quantitatively and qualitatively among the same group of tumours under various conditions. Both antisera stained smooth and skeletal muscle and Marangos' anterisa to a lesser extent. They also compared the commercially available Polysciences antisera with bovine NSE available from Dakopatts. Their results suggested that bovine NSE was superior in terms of consistency, reliability, and low degree of cross reactivity. They found Petrusky's technique superior to Sternberger's PAP technique when using Polysciences antisera, but this was not the case when antisera obtained from Dako was used. 21 Nuclear labelling with NSE antisera may also be found. Schmechel et al5 attributed such nuclear staining to poor fixation. Haan et a128 found nuclear staining most strong at a slightly acidic or neutral pH. They found it less strong when the pH of a second fixative solution was 9-5 and absent when the pH was increased to 11.
A small number of cases that were initially included in the study had to be withdrawn as nerve fibres, which were included in the blocks, consistently failed to stain with NSE antiserum despite the positive control sections in the same batch staining intensely. We were unable to determine the reasons for this, but it does highlight the technical difficulties entailed in the use of this antiserum.
In conclusion, NSE is not a specific marker for neuroendocrine tumours. If it is known with which tissues and tumours it will cross react, however, then NSE antiserum may be useful in confirming the diagnosis of carcinoid tumours, oat cell carcinomas, and malignant melanomas.
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